Sanofi-aventis is committed to helping patients with ALS and their caregivers. RILUTEK is covered by most healthcare insurance providers and managed care plans as well as Medicare, Medicaid, and other state programs. The RILUTEK Care™ Program was created to help patients get the most out of their treatment and offers 3 patient assistance programs to help meet patients’ needs. Call 1-800-RILUTEK to learn more.

RILUTEK Care™ Connection Program
helps patients learn about all their coverage options:

• This program makes outgoing calls to:
  • Insurance companies to verify coverage availability and determine claims or overview instructions
  • Medicare, Medicaid, or other state programs to determine coverage availability
  • Various agencies to determine coverage availability
• This program researches databases to determine coverage availability for Medicare, Medicaid, or other state programs
• This program provides coding and insurance application information

RILUTEK Care™ Patient Assistance Program
has helped cover the cost of RILUTEK for thousands of eligible patients:

• This program provides an equal opportunity for ALS patients to receive treatment with RILUTEK
• This program is administered by the National Organization for Rare Disorders (NORD)
  
  • Eligibility is determined solely by medical and financial criteria
  • All eligibility decisions are made by NORD
• This program provides co-payment assistance for RILUTEK prescriptions

RILUTEK Care™ Hotline: 1-800-RILUTEK
This toll-free service provides ALS patients with the following free services:

• Complete pharmacy services
• Assistance with insurance forms and claims, including job loss or change
• Electronic claims processing, where permitted by the plan
• Advocacy if claim is delayed, denied, or sent to a case manager
• Assistance with accessing federal and state payment programs
• Referral to the RILUTEK Care™ Patient Assistance Program

Click here for information on Government Assistance